K Pharma,Inc.
Develops iPS cell-derived treatments for central nervous system disorders.
4896 | T
Overview
Corporate Details
- ISIN(s):
- JP3280900006
- LEI:
- Country:
- Japan
- Address:
- 港区六本木七丁目7番7号
- Website:
- https://en.kpharma.co.jp/
- Sector:
- Manufacturing
Description
K Pharma, Inc. is a biotechnology company that specializes in medical treatments derived from induced pluripotent stem (iPS) cell technology. The company's operations are centered on two key areas: iPS drug discovery and regenerative medicine. Its research, development, manufacturing, and sales activities are primarily focused on the central nervous system (CNS), with a specific emphasis on nerve regeneration. K Pharma develops therapies for conditions such as spinal cord injuries and cerebral infarctions by utilizing disease-specific iPS cells. The company was established as a spin-off venture from the Keio University School of Medicine to commercialize advanced academic research.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-13 07:01 |
確認書
|
Japanese | 8.8 KB | ||
| 2023-11-13 07:00 |
四半期報告書-第7期第3四半期(2023/07/01-2023/09/30)
|
Japanese | 151.5 KB | ||
| 2023-10-17 02:33 |
臨時報告書
|
Japanese | 21.9 KB | ||
| 2023-10-06 08:00 |
訂正有価証券届出書(新規公開時)
|
Japanese | 1.6 MB | ||
| 2023-09-28 04:00 |
訂正有価証券届出書(新規公開時)
|
Japanese | 1.6 MB | ||
| 2023-09-12 08:00 |
有価証券届出書(新規公開時)
|
Japanese | 3.0 MB |
Automate Your Workflow. Get a real-time feed of all K Pharma,Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for K Pharma,Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for K Pharma,Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||